NCT06697782 2025-01-22
Aprepitant and Ondansetron Monotherapy or Combination for Postoperative Nausea and Vomiting in Thyroid Cancer
The First Affiliated Hospital of Zhengzhou University
Phase 4 Completed
Clinical Trials
5 trialsNCT01636947 2018-09-25
KMEC
Merck Sharp & Dohme LLC
Phase 4 Completed
NCT01913990 2017-01-30
ER11-02
Ottawa Hospital Research Institute
Phase 4 Unknown
NCT02441894 2017-01-24
PEGAZUS
Sanofi
Phase 4 Completed
NCT01896440 2013-10-08
Heart Safety Study of Ondansetron in Children Receiving Chemotherapy
University of Oklahoma
Phase 4 Withdrawn